AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32705703 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT) with minimal support
Number of subjects: 12
Study 32705703 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT)
Number of subjects: 12
Study 35100190 — intervention group
Group type: EXPERIMENTAL
Intervention: Short storage RBCs (stored for up to seven days)
Number of subjects: 146
Study 35100190 — intervention group
Group type: COMPARATOR
Intervention: Standard issue RBCs
Number of subjects: 146
Study 35100190 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfused patients
Number of subjects: 146
Study 34330457 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (1 g/day) for 12 weeks
Number of subjects: 43
Study 34330457 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corn starch) for 12 weeks
Number of subjects: 43
Study 35791031 — intervention group
Group type: EXPERIMENTAL
Intervention: LASSO-derived nomogram
Number of subjects: 1883
Study 35665279 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative nursing combined with thinking map health education
Number of subjects: 60
Study 35665279 — intervention group
Group type: COMPARATOR
Intervention: Narrative nursing
Number of subjects: 60
Study 32375747 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular, low-dose (≤32 mg/day), sustained-release morphine for chronic breathlessness associated with COPD
Number of subjects: 26
Study 32375747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 35347300 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily tadalafil plus early low-intensity shock wave therapy (LI-SWT)
Number of subjects: 80
Study 35347300 — intervention group
Group type: COMPARATOR
Intervention: Daily tadalafil only
Number of subjects: 80
Study 33598702 — intervention group
Group type: EXPERIMENTAL
Intervention: Storybook about home hazards (intervention group, N=29)
Number of subjects: 59
Study 33598702 — intervention group
Group type: COMPARATOR
Intervention: Storybook about healthy eating (control group, N=30)
Number of subjects: 59
Study 32320842 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intensive treatment approach using one of four monoclonal antibodies as initial therapy.
Number of subjects: 400
Study 32320842 — intervention group
Group type: COMPARATOR
Intervention: Escalation treatment approach using any other approved medication as initial therapy with subsequent escalation to higher efficacy treatments.
Number of subjects: 400
Study 34368905 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsilateral ST graft harvest
Number of subjects: 140
Study 34368905 — intervention group
Group type: COMPARATOR
Intervention: Contralateral ST graft harvest
Number of subjects: 140
Study 34368905 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 140
Study 34970881 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with thunder‐fire moxibustion
Number of subjects: 94
Study 34970881 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture alone (Control group)
Number of subjects: 94
Study 34509329 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid hyrax (HH) expander
Number of subjects: 40
Study 34509329 — intervention group
Group type: COMPARATOR
Intervention: Conventional hyrax (CH) expander
Number of subjects: 40
Study 35023564 — intervention group
Group type: EXPERIMENTAL
Intervention: Messaging on mortality effects of VLNC cigarettes
Number of subjects: 1177
Study 35023564 — intervention group
Group type: EXPERIMENTAL
Intervention: Messaging on morbidity or mortality effects of VLNC cigarettes
Number of subjects: 1177
Study 35023564 — intervention group
Group type: COMPARATOR
Intervention: Control message
Number of subjects: 1177
Study 35477046 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT)
Number of subjects: 4
Study 35477046 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy
Number of subjects: 4
Study 35477046 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine
Number of subjects: 4
Study 35477046 — intervention group
Group type: COMPARATOR
Intervention: Hydrogen peroxide
Number of subjects: 4
Study 35960897 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy (IMRT)
Number of subjects: 279
Study 35960897 — intervention group
Group type: COMPARATOR
Intervention: Conventional Radiation Therapy (CRT)
Number of subjects: 279
Study 33123718 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled reoxygenation (normoxia)
Number of subjects: 90
Study 33123718 — intervention group
Group type: COMPARATOR
Intervention: Hyperoxic CPB
Number of subjects: 90
Study 32785490 — intervention group
Group type: COMPARATOR
Intervention: Non-inferiority experimental group
Number of subjects: 0
Study 32785490 — intervention group
Group type: COMPARATOR
Intervention: Non-inferiority margin determination
Number of subjects: 0
Study 32785490 — intervention group
Group type: COMPARATOR
Intervention: Sample size calculation
Number of subjects: 0
Study 32785490 — intervention group
Group type: COMPARATOR
Intervention: Data final analysis
Number of subjects: 0
Study 35929037 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Dexmedetomidine (Dex) and Butorphanol (But)
Number of subjects: 208
Study 35929037 — intervention group
Group type: COMPARATOR
Intervention: Control group (A)
Number of subjects: 208
Study 35929037 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine (Dex)
Number of subjects: 208
Study 35929037 — intervention group
Group type: COMPARATOR
Intervention: Butorphanol (But)
Number of subjects: 208
Study 36469353 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed incentives
Number of subjects: 668
Study 36469353 — intervention group
Group type: EXPERIMENTAL
Intervention: Outcome-based incentives
Number of subjects: 668
Study 36469353 — intervention group
Group type: COMPARATOR
Intervention: Resources-only group
Number of subjects: 668
Study 33887240 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 200
Study 33887240 — intervention group
Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 200
Study 33041028 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleotide supplementation (2 g/d)
Number of subjects: 20
Study 616503306 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy-related factors (patient-rated pretreatment credibility and early therapeutic alliance)
Number of subjects: 56
Study 616503306 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-transcendence
Number of subjects: 56
Study 34407654 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 70 and 140 mg
Number of subjects: 1602
Study 34407654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1602
Study 32349746 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid with information plus an implicit VCM
Number of subjects: 276
Study 32349746 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid with information plus an explicit VCM
Number of subjects: 276
Study 32349746 — intervention group
Group type: COMPARATOR
Intervention: Decision aid with information only (control)
Number of subjects: 276
Study 33310265 — intervention group
Group type: COMPARATOR
Intervention: Resistance Training (RT)
Number of subjects: 86
Study 33310265 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Training (AT)
Number of subjects: 86
Study 33310265 — intervention group
Group type: EXPERIMENTAL
Intervention: Control (CN)
Number of subjects: 86
Study 32035553 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional brace
Number of subjects: 540
Study 32035553 — intervention group
Group type: COMPARATOR
Intervention: Plaster cast
Number of subjects: 540
Study 35366822 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniocervical muscle‐strengthening exercise (CMSE) for 8 weeks
Number of subjects: 42
Study 35366822 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound treatment for 8 weeks
Number of subjects: 42
Study 35366822 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniocervical muscle‐strengthening exercise (CMSE)
Number of subjects: 42
Study 33753537 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKAs) with target INR of 2-3
Number of subjects: 132
Study 33753537 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg daily
Number of subjects: 132
Study 33753537 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban and vitamin K2
Number of subjects: 132
Study 33753537 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 132
Study 33753537 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled rivaroxaban groups
Number of subjects: 132
Study 33203477 — intervention group
Group type: EXPERIMENTAL
Intervention: Biannual community-wide treatment (CWT)
Number of subjects: 167500
Study 33203477 — intervention group
Group type: COMPARATOR
Intervention: Annual school-based treatment (SBT)
Number of subjects: 167500
Study 33203477 — intervention group
Group type: COMPARATOR
Intervention: Annual CWT
Number of subjects: 167500
Study 33203477 — intervention group
Group type: EXPERIMENTAL
Intervention: Biannual CWT
Number of subjects: 167500
Study 35020706 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention using MyFitnessPal app, smart scale, and text messages
Number of subjects: 70
Study 35020706 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 70
Study 32694382 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning analysis of pain parameters
Number of subjects: 320
Study 32694382 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster assignment
Number of subjects: 320
Study 32694382 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision trees trained with demographic and pain-related variables
Number of subjects: 320
Study 32694382 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep problems
Number of subjects: 320
Study 32694382 — intervention group
Group type: EXPERIMENTAL
Intervention: Parameters including fear of pain, self-rated poor health, and systolic blood pressure
Number of subjects: 320
Study 36111922 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 60
Study 36111922 — intervention group
Group type: COMPARATOR
Intervention: Placebo TEAS (no electrical output)
Number of subjects: 60
Study 34034753 — intervention group
Group type: EXPERIMENTAL
Intervention: MPK C-Leg + 1M10 foot
Number of subjects: 10
Study 34034753 — intervention group
Group type: COMPARATOR
Intervention: NMPK with standardized 1M10 foot
Number of subjects: 10
Study 35640787 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 27
Study 35640787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 32605910 — intervention group
Group type: EXPERIMENTAL
Intervention: Eryaspase
Number of subjects: 113
Study 32605910 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA positive at baseline
Number of subjects: 113
Study 32605910 — intervention group
Group type: EXPERIMENTAL
Intervention: Early change in ctDNA levels
Number of subjects: 113
Study 36459265 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary ureteroscopy (URS) without pre-stenting
Number of subjects: 120
Study 36459265 — intervention group
Group type: COMPARATOR
Intervention: Deferred ureteroscopy (URS) after ureteric stenting
Number of subjects: 120
Study 33279558 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate binder prescriptions and dietary recommendations to achieve 'Hi' serum phosphate target (≥6.5 mg/dl)
Number of subjects: 4400
Study 33279558 — intervention group
Group type: COMPARATOR
Intervention: Phosphate binder prescriptions and dietary recommendations to achieve 'Lo' serum phosphate target (<5.5 mg/dl)
Number of subjects: 4400
Study 33983524 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite self-management program (Manage at Work)
Number of subjects: 119
Study 33983524 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 119
Study 34794388 — intervention group
Group type: EXPERIMENTAL
Intervention: iGuide intervention (includes video vignettes and a live webinar)
Number of subjects: 0
Study 34794388 — intervention group
Group type: EXPERIMENTAL
Intervention: iGuide intervention (includes electronic health records-based communication and case-based webinars)
Number of subjects: 0
Study 34794388 — intervention group
Group type: EXPERIMENTAL
Intervention: iGuide intervention
Number of subjects: 0
Study 34794388 — intervention group
Group type: COMPARATOR
Intervention: Education-only control
Number of subjects: 0
Study 33579326 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious game training
Number of subjects: 8
Study 33579326 — intervention group
Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 8
Study 33579326 — intervention group
Group type: COMPARATOR
Intervention: Machine learning controlled prosthesis
Number of subjects: 8
Study 32753845 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride 1 mg (test formulation)
Number of subjects: 72
Study 32753845 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride 1 mg (reference formulation)
Number of subjects: 72
Study 32753845 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations of glimepiride
Number of subjects: 72
Study 35144658 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable activity device and personal consultations (subgroup A)
Number of subjects: 129
Study 35144658 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable activity device (subgroup B)
Number of subjects: 129
Study 35144658 — intervention group
Group type: COMPARATOR
Intervention: No support (subgroup C)
Number of subjects: 129
Study 33389265 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% humate (H)
Number of subjects: 192
Study 33389265 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% probiotic (P)
Number of subjects: 192
Study 33389265 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15% humate + 0.15% probiotic (HP)
Number of subjects: 192
Study 33389265 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 192
Study 35373894 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Closed Loop (HCL)
Number of subjects: 38
Study 35373894 — intervention group
Group type: COMPARATOR
Intervention: Sensor-Augmented Pump (SAP)
Number of subjects: 38
Study 35373894 — intervention group
Group type: COMPARATOR
Intervention: Predictive Low-Glucose Management (PLGM)
Number of subjects: 38
Study 35373894 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall HbA1c
Number of subjects: 38
Study 35373894 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes burden and worries and fear of hypoglycaemia
Number of subjects: 38
Study 35373894 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety events
Number of subjects: 38
Study 33748923 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-Oss collagen
Number of subjects: 40
Study 33748923 — intervention group
Group type: COMPARATOR
Intervention: No grafting material
Number of subjects: 40
Study 32727231 — intervention group
Group type: COMPARATOR
Intervention: Iodine-alcohol
Number of subjects: 2013
Study 32727231 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 2013
Study 32727231 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-alcohol
Number of subjects: 2013
Study 32727231 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-alcohol and iodine combined
Number of subjects: 2013
Study 32202698 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized spacer region in the translation initiation site; specific details on dosage and duration not available.
Number of subjects: 0
Study 35197416 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading group A (n=81)
Number of subjects: 158
Study 35197416 — intervention group
Group type: COMPARATOR
Intervention: Conventional loading group B (n=77)
Number of subjects: 158
Study 32413693 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal P-wave axis (PWA)
Number of subjects: 8899
Study 32413693 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal P-wave axis (PWA) after multivariable adjustment
Number of subjects: 8899
Study 35156782 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional dysregulation
Number of subjects: 51
Study 35156782 — intervention group
Group type: EXPERIMENTAL
Intervention: Worry trait
Number of subjects: 51
Study 35156782 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance of internal experiences
Number of subjects: 51
Study 35156782 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion
Number of subjects: 51
Study 35156782 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful state
Number of subjects: 51
Study 35156782 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion as a mediator
Number of subjects: 51
Study 32586693 — intervention group
Group type: EXPERIMENTAL
Intervention: The Senior Connection (TSC)
Number of subjects: 0
Study 32586693 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 0
Study 36088952 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin-clavulanic acid (75 mg/kg amoxicillin + 18.75 mg/kg clavulanic acid, given daily in three doses for 7 days)
Number of subjects: 510
Study 36088952 — intervention group
Group type: COMPARATOR
Intervention: Intravenous antibiotics (according to local protocol, for 7 days)
Number of subjects: 510
Study 36088952 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin-clavulanic acid
Number of subjects: 510
Study 36088952 — intervention group
Group type: COMPARATOR
Intervention: Intravenous antibiotics
Number of subjects: 510
Study 33415863 — intervention group
Group type: EXPERIMENTAL
Intervention: Long snake moxibustion
Number of subjects: 120
Study 33415863 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashi-point moxibustion
Number of subjects: 120
Study 33415863 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 35641143 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) over the dorsal premotor cortex during ischemic nerve block (INB)
Number of subjects: 0
Study 35641143 — intervention group
Group type: COMPARATOR
Intervention: Sham TMS over the parietal area during ischemic nerve block (INB)
Number of subjects: 0
Study 33704378 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 Gy SDRT
Number of subjects: 30
Study 33704378 — intervention group
Group type: COMPARATOR
Intervention: 5 × 9 Gy SBRT
Number of subjects: 30
Study 32584174 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (10 mg/site)
Number of subjects: 6
Study 32584174 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine HCl (10 mg/site)
Number of subjects: 6
Study 32584174 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Number of subjects: 6
Study 32584174 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine HCl
Number of subjects: 6
Study 35688444 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperosmolar saline (593 mOsm/L)
Number of subjects: 46
Study 35688444 — intervention group
Group type: COMPARATOR
Intervention: Isotonic lactated Ringer's (273 mOsm/L)
Number of subjects: 46
Study 34633280 — intervention group
Group type: EXPERIMENTAL
Intervention: Unitisation intervention
Number of subjects: 45
Study 34633280 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 45
Study 33075100 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit intervention
Number of subjects: 29
Study 34112721 — intervention group
Group type: EXPERIMENTAL
Intervention: OxyGenie control (SLE6000 ventilator)
Number of subjects: 15
Study 34112721 — intervention group
Group type: COMPARATOR
Intervention: CLiO2 control (AVEA ventilator)
Number of subjects: 15
Study 32046652 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners (GPs)
Number of subjects: 1121
Study 32046652 — intervention group
Group type: COMPARATOR
Intervention: Nursing home (NH) staff
Number of subjects: 1121
Study 36130170 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month culturally tailored Facebook group intervention
Number of subjects: 60
Study 36130170 — intervention group
Group type: COMPARATOR
Intervention: Referral resources on evidence-based cessation treatments (control)
Number of subjects: 60
Study 33676997 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconnection to mechanical ventilation (MV) for 1 hour after successful spontaneous breathing trial (SBT)
Number of subjects: 336
Study 33676997 — intervention group
Group type: COMPARATOR
Intervention: Direct extubation (DE)
Number of subjects: 336
Study 33676997 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconnection to MV for 1 hour after SBT (among patients ventilated for more than 72 hours)
Number of subjects: 336
Study 33676997 — intervention group
Group type: COMPARATOR
Intervention: Direct extubation (DE) (among patients ventilated for more than 72 hours)
Number of subjects: 336
Study 33185670 — intervention group
Group type: COMPARATOR
Intervention: Evolocumab, 140 mg every 2 weeks or 420 mg monthly
Number of subjects: 3187
Study 33185670 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin, 40 mg daily for 30 days followed by 80 mg daily thereafter
Number of subjects: 3187
Study 33185670 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe, 10 mg daily plus simvastatin, 40 mg daily
Number of subjects: 3187
Study 35962423 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Anger Response Questionnaire for Children (BARQC-V)
Number of subjects: 1084
Study 35962423 — intervention group
Group type: EXPERIMENTAL
Intervention: Maladaptive anger coping styles (Rumination and Direct Anger-out)
Number of subjects: 1084
Study 35962423 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive anger coping style (Assertion)
Number of subjects: 1084
Study 34110701 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose ingestion (CHO) - 300 ml water containing 75 g glucose
Number of subjects: 8
Study 34110701 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose ingestion (CHO)
Number of subjects: 8
Study 34110701 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) - placebo
Number of subjects: 8
Study 33407507 — intervention group
Group type: EXPERIMENTAL
Intervention: KCG metrics computed on 50 Hz SCG/BCG signals
Number of subjects: 12
Study 33407507 — intervention group
Group type: EXPERIMENTAL
Intervention: KCG metrics computed on 1 kHz SCG/BCG signals
Number of subjects: 12
Study 32331899 — intervention group
Group type: EXPERIMENTAL
Intervention: TMR conversion at 8 weeks (T8)
Number of subjects: 40